Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Carolyn Rand (interim)
|
| gptkbp:collaboratedWith |
gptkb:Zai_Lab
gptkb:Takeda_Pharmaceutical_Company |
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
immuno-oncology
antibody therapeutics |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:Mike_Romanos
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Crescendo Biologics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:openToPublic |
private
|
| gptkbp:platform |
Humabody
|
| gptkbp:products |
CB213
CB307 |
| gptkbp:specializesIn |
Humabody therapeutics
|
| gptkbp:website |
https://www.crescendobiologics.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|